3SOF

Profile:  



Neurochem Inc.
275 Armand-Frappier Boulevard
Laval, QC H7V 4A7
Canada - Map
Phone: 450-680-4500
Fax: 450-680-4501
Web Site: http://www.neurochem.com

DETAILS  
Index Membership: N/A
Sector: Healthcare
Industry: Drug Manufacturers - Other
Full Time Employees: 184


BUSINESS SUMMARY  
Neurochem, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics primarily for the treatment of neurological disorders. Its product candidates include eprodisate, which has completed Phase III clinical trial for the treatment of amyloid A amyloidosis. The company is seeking marketing approval of eprodisate from U.S. Food and Drug Administration and European Medicines Agency. Its product candidates also comprise tramiprosate, a Phase III clinical trial product for the treatment of Alzheimer's disease; and tramiprosate, a Phase IIa clinical trial completed product for the treatment of hemorrhagic stroke due to cerebral amyloid angiopathy. Neurochem was founded in 1993 and is based in Laval, Canada.

Every chart paints its own picture...This one looks very good !
Closed a gap...going for the next 



52wk Range: 2.12 - 26.51
Volume: 3,084,570
Avg Vol (3m): 879,882

Technicals
Percentage Gainer

Last Price Quote is:
56.02%above 13-day MA
22.33%above 50-day MA
RS Rating: 12 

Fundamentals
Key Data:
Market Cap (M): $136.89 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: 11/07/2007
Last Analyst Rating: Hold